(Q33427356)

English

Phase-I trial of intravenous continuous infusion of tumor necrosis factor in advanced metastatic carcinomas

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Phase-I trial of intravenous continuous infusion of tumor necrosis factor in advanced metastatic carcinomas (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

phase I clinical trial

0 references

author name string

Wiedenmann B

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Reichardt P

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Räth U

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Theilmann L

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Schüle B

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Ho AD

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Schlick E

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kempeni J

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Hunstein W

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kommerell B

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

1 January 1989

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

115

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

189-192

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Cachectin: more than a tumor necrosis factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/2654135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of recombinant tumor necrosis factor in cancer patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2654135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/2654135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decrease of natural killer cell activity and monokine production in peripheral blood of patients treated with recombinant tumor necrosis factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/2654135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identity of tumour necrosis factor and the macrophage-secreted factor cachectin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2654135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/2654135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2654135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal cell carcinoma: antitumor effects of leukocyte interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/2654135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An endotoxin-induced serum factor that causes necrosis of tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2654135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of the growth and differentiation of erythroid precursor cells by an endotoxin-induced mediator from peritoneal macrophages

1 reference

https://pubmed.ncbi.nlm.nih.gov/2654135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/2654135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Discrimination of hepatocyte-stimulating activity from human recombinant tumor necrosis factor alpha

1 reference

https://pubmed.ncbi.nlm.nih.gov/2654135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human tumor necrosis factor. Production, purification, and characterization

1 reference

https://pubmed.ncbi.nlm.nih.gov/2654135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular cloning of the complementary DNA for human tumor necrosis factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/2654135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reporting results of cancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/2654135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary structure of human lymphotoxin derived from 1788 lymphoblastoid cell line

1 reference

https://pubmed.ncbi.nlm.nih.gov/2654135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00397922

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33427356&oldid=2195351888"